Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A20 (TNFAIP3) Alterations in Primary Intestinal Diffuse Large B-cell Lymphoma.

Acta medica Okayama - 1 Feb 2018

Fujii Masayoshi, Takata Katsuyoshi, Chuang Shih-Sung, Miyata-Takata Tomoko, Ando Midori, Sato Yasuharu, Yoshino Tadashi

Abstract excerpt

The gastrointestinal (GI) tract is the most frequently involved site of extranodal non-Hodgkin lymphomas, and diffuse large B-cell lymphoma (DLBCL) is the most common subtype occurring in the GI tract. TNFAIP3 (A20) genetic alterations were reported to be involved in DLBCL's pathogenesis and a portion of GI-DLBCL cases harbor this alteration. However, the frequency and clinicopathological relations focusing on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Gastrointestinal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Deletion

Share to Gene Expression Regulation, Neoplastic

Share to Lymphoma, Large B-Cell, Diffuse

Share to Tumor Necrosis Factor alpha-Induced Protein 3

Share to Young Adult

Source

Identifiers

PMID: 29463935
DOI: 10.18926/AMO/55659

Genes

TNFAIP3
BCL6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A20 (TNFAIP3) Alterations in Primary Intestinal Diffuse Large B-cell Lymphoma.PMID 29463935Read ↗

Clinicopathological features of 49 primary gastrointestinal diffuse large B-cell lymphoma cases; comparison with location, cell-of-origin, and frequency of MYD88 L265P.Semantic proximity Read ↗

Heterogeneity in primary gastrointestinal DLBCL: from clinical management to molecular mechanisms and treatment strategies.Semantic proximity Read ↗

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma.Semantic proximity Read ↗

Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment.Semantic proximity Read ↗

Differences in mutational signature of diffuse large B-cell lymphomas according to the primary organ.Semantic proximity Read ↗

Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphomaSemantic proximity Read ↗

Differences in germinal centre and non-germinal center phenotype in gastric and intestinal diffuse large B-cell lymphomas.Semantic proximity Read ↗

EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features.Semantic proximity Read ↗

First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in CXCR4 and TRAF3 genes.Semantic proximity Read ↗

Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.Semantic proximity Read ↗

A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.